Cargando…

Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats

BACKGROUND: During acute respiratory distress syndrome, proinflammatory mediators inhibit natural anticoagulant factors, which alter the normal balance between coagulation and fibrinolysis leading to a procoagulant state. We hypothesize that pulmonary administration of anticoagulants might be benefi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camprubí‐Rimblas, Marta, Tantinyà, Neus, Guillamat‐Prats, Raquel, Bringué, Josep, Puig, Ferranda, Gómez, Maria Nieves, Blanch, Lluís, Artigas, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906372/ https://www.ncbi.nlm.nih.gov/pubmed/31755229 http://dx.doi.org/10.1111/jth.14685

Ejemplares similares

Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
por: Chimenti, Laura, et al.
Publicado: (2017)

Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats
por: Guillamat-Prats, Raquel, et al.
Publicado: (2020)

Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury
por: Camprubí–Rimblas, Marta, et al.
Publicado: (2017)

Methotrexate Ameliorates Systemic Inflammation and Septic Associated-Lung Damage in a Cecal Ligation and Puncture Septic Rat Model
por: Bringué, Josep, et al.
Publicado: (2021)

Comparison of direct and indirect models of early induced acute lung injury
por: Chimenti, Laura, et al.
Publicado: (2020)

Heparin effect in alveolar cells and macrophages in an acute lung injury model
por: Camprubí-Rimblas, M, et al.
Publicado: (2015)

0991. Nebulized heparin reduces pulmonary inflammatory responses in a rat model of acute lung injury
por: Chimenti, L, et al.
Publicado: (2014)

Effect of the alveolar type ii cells transplantation for the treatment of acute lung injury
por: Guillamat-Prats, R, et al.
Publicado: (2015)

Interactions of nebulized heparin with intravenous antithrombin for combined therapy of acute lung injury
por: Rehberg, S, et al.
Publicado: (2011)

Role of Mesenchymal Stem/Stromal Cells in Coagulation
por: Guillamat-Prats, Raquel
Publicado: (2022)

The role of hypercapnia in acute respiratory failure
por: Morales-Quinteros, Luis, et al.
Publicado: (2019)

Barrier-Protective Effects of Activated Protein C in Human Alveolar Epithelial Cells
por: Puig, Ferranda, et al.
Publicado: (2013)

Nebulized heparin reduces levels of pulmonary coagulation activation in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2010)

Successful use of an antithrombin for heparin resistance with andexanet alfa
por: Honda, Jun, et al.
Publicado: (2023)

Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats
por: Hofstra, Jorrit J, et al.
Publicado: (2009)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
por: Gindele, Réka, et al.
Publicado: (2021)

Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis
por: Rojnik, Tamara, et al.
Publicado: (2023)

Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?
por: Seam, Nitin, et al.
Publicado: (2014)

Influence of high‐dose antithrombin on platelet function and blood coagulation
por: Miike, Toru, et al.
Publicado: (2021)

Nebulized Heparin for Post-COVID-19-Related Hypoxia
por: Hursitoglu, Mehmet, et al.
Publicado: (2021)

The Role of MSC in Wound Healing, Scarring and Regeneration
por: Guillamat-Prats, Raquel
Publicado: (2021)

Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site
por: Bohdan, Nataliya, et al.
Publicado: (2016)

Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Akahoshi, Tomohiko, et al.
Publicado: (2022)

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
por: van Haren, Frank M. P., et al.
Publicado: (2020)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017)

Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
por: Wada, Takeshi, et al.
Publicado: (2022)

Nebulized heparin and N-acetylcysteine for smoke inhalational injury: A case report
por: Ashraf, Umair, et al.
Publicado: (2018)

Nebulized Heparin in Burn Patients with Inhalation Trauma—Safety and Feasibility
por: Glas, Gerie J., et al.
Publicado: (2020)

Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy
por: Fiskvik, Hilde, et al.
Publicado: (2021)

Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure
por: Kuroda, Hiromitsu, et al.
Publicado: (2020)

Heparin beyond anti-coagulation
por: Chen, Daohong
Publicado: (2021)

Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013)

Modifications of coagulation imbalance during antithrombin treatment in preeclamptic patients: our experience
por: Buscemi, C, et al.
Publicado: (2008)

Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
por: Nakahara, Kazunari, et al.
Publicado: (2013)

Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014)

A phase 1 trial of nebulized heparin in acute lung injury
por: Dixon, B, et al.
Publicado: (2008)

Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury
por: Xie, Nianlin, et al.
Publicado: (2017)

Effect of unfractionated and low molecular weight heparin on microcirculatory antithrombin effects during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition
por: Rashid, Qudsia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bq7nhr62cuksgk7d10jueppuk6